REQUEST A DEMO
Total
USD $0.00
Search more companies

Roche D.O.O. Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Roche D.O.O. Beograd Profile Updated: July 06, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Roche D.O.O. Beograd is based in Serbia, with the head office in Belgrade. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on May 09, 2005. Roche D.O.O. Beograd currently employs 60 (2019) people. In its most recent financial highlights, the company reported a net sales revenue increase of 22.25% in 2022. Its’ total assets recorded a growth of 5.67%. In 2022, Roche D.O.O. Beograd’s net profit margin decreased by 0.43%.

Headquarters
Vladimira Popovica 8a
Belgrade; Belgrade;

Contact Details: Purchase the Roche D.O.O. Beograd report to view the information.

Website: http://www.roche.com

Basic Information
Total Employees:
Purchase the Roche D.O.O. Beograd report to view the information.
Outstanding Shares:
Purchase the Roche D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Roche D.O.O. Beograd report to view the information.
Financial Auditors:
Purchase the Roche D.O.O. Beograd report to view the information.
Incorporation Date:
May 09, 2005
Key Executives
Purchase this report to view the information.
Acting General Director
Purchase this report to view the information.
Procurator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Roche D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
22.25%
Total operating revenue
22.24%
Operating profit (EBIT)
12.09%
EBITDA
12.97%
Net Profit (Loss) for the Period
-5.57%
Total assets
5.67%
Total equity
6.53%
Operating Profit Margin (ROS)
-0.32%
Net Profit Margin
-0.43%
Return on Equity (ROE)
-0.79%
Debt to Equity Ratio
-1.17%
Quick Ratio
-0.07%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?